--- title: "NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab" ocid: "ocds-r6ebe6-0000747438" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000747438" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000747438.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000747438.json" source: "Public Contracts Scotland" current_stage: "Tender" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)" published: "2023-10-20" --- # NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) Current stage: Tender OCID: ocds-r6ebe6-0000747438 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000747438) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000747438.json) ## Summary The public procurement contracting process is led by The Common Services Agency (NHS National Services Scotland) in Edinburgh, UK. The tender titled "NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab" falls under the "Health" industry category. The procurement method is an open procedure with an estimated value of 92,000,000 GBP. The tender deadline for submission is November 21, 2023. The tender aims to supply adalimumab, tocilizumab, and eculizumab to NHS Scotland. This tender presents significant business growth opportunities for suppliers of medical supplies within the health industry. Companies capable of providing high-quality pharmaceutical products in compliance with regulatory standards are well-suited to compete. The tender's focus on multiple product lines and potential framework participation allows for a diverse range of businesses to engage and potentially secure long-term contracts for the supply of crucial medicines to NHS Scotland. ## Notice Supply of adalimumab, tocilizumab and eculizumab to NHS Scotland. ### Lot Information NP47923c Eculizumab Supply of eculizumab vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. NP47923b Tocilizumab Supply of tocilizumab pre-filled pens/devices, pre-filled syringes and vials to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants. This Lot will be awarded from 1 March 2024, for 12 months, with an expiry date of 28 February 2025. This Lot has the option to extend by any number of periods, up to the maximum 36 months. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. NP47923a Adalimumab Supply of Adalimumab pre-filled pens/devices and pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of six (6) Framework Participants. This Lot will be awarded from 1 March 2024, for 24 months, with an expiry date of 28 February 2026. This Lot has the option to extend by any number of periods, up to the maximum 24 months. Full details of Goods and volumes can be found within the ITT documents. Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT490936 | | Notice type | OJEU - F2 - Contract Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 20 Oct 2023 | | Submission deadline | 21 Nov 2023 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £92,000,000 | | Lots value | £94,015,132 | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 20 Oct 2023 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT490936 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT490936 NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab - Supply of adalimumab, tocilizumab and eculizumab to NHS Scotland. ## Notice URLs - http:// - http://publictendersscotland.publiccontractsscotland.gov.uk - http://www.nss.nhs.scot/browse/procurement-and-logistics - http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 - http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000747438 - https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ - https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/ - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000747438. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000747438.json.